Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Immunother. 2010 Oct;33(8):780–788. doi: 10.1097/CJI.0b013e3181ee6675

Figure 3. CCR2b transduced ATCs exhibit enhanced tumor trafficking in vivo.

Figure 3

A) SCID mice received a s.c. injection in the right flank with SK-N-SH (CCL2+) tumor cells followed i.v. injection of ATCs transduced with EGFPluc alone, or with EGFPluc and CCR2b. Following injection, ATCs were monitored by bioluminescence imaging for 72 hours. B) Bioluminescence was calculated by region of interest (ROI) analysis at the tumor site.